Taiwan FDA registration 3e7c548b529a8060afcb02e11898cd18
“Medispec” Extracorporeal Shock Wave Therapy System
TW: “麥迪斯派克”體外震波治療儀
Taiwan·Risk Class 3·MD·Medispec Ltd.·Registered Aug 23, 2016 – Aug 23, 2026ActiveRegistration details
- Analysis ID
- 3e7c548b529a8060afcb02e11898cd18
- License Form
- Ministry of Health Medical Device Import No. 028168
- Customs Code
- DHA05602816804
Company information
- Manufacturer
- Medispec Ltd.
- Manufacturer Country
- Israel
- Authorized Representative
- SHARPMED INSTRUMENTS CO., LTD.
Product details
- Intended Use
- 1. Treatment of vascular erectile dysfunction. 2. Chronic pelvic pain syndrome in men.
- Product Type (Level 1)
- H Gastroenterology-urology devices
- Product Type (Level 2)
- H9999 Other
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Aug 23, 2016
- Expiry Date
- Aug 23, 2026
About this record
Access comprehensive regulatory information for “Medispec” Extracorporeal Shock Wave Therapy System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 3e7c548b529a8060afcb02e11898cd18 and manufactured by Medispec Ltd.. The authorized representative in Taiwan is SHARPMED INSTRUMENTS CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices